MedPath

CEFACLOR

CEFACLOR CAPSULES USP AND CEFACLOR FOR ORAL SUSPENSION USPRx only

Approved
Approval ID

9e8890f0-e04a-4555-ac8d-d1b792a5c276

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 20, 2011

Manufacturers
FDA

Rebel Distributors Corp

DUNS: 118802834

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

CEFACLOR

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code21695-782
Application NumberANDA064164
Product Classification
M
Marketing Category
C73584
G
Generic Name
CEFACLOR
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 15, 2008
FDA Product Classification

INGREDIENTS (10)

CefaclorActive
Quantity: 250 mg in 5 mL
Code: 69K7K19H4L
Classification: ACTIB
citric acidInactive
Code: 2968PHW8QP
Classification: IACT
FD&C RED NO. 40Inactive
Code: WZB9127XOA
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
STRAWBERRYInactive
Code: 4J2TY8Y81V
Classification: IACT
DIMETHICONEInactive
Code: 92RU3N3Y1O
Classification: IACT
sodium benzoateInactive
Code: OJ245FE5EU
Classification: IACT
sodium citrateInactive
Code: 1Q73Q2JULR
Classification: IACT
sucroseInactive
Code: C151H8M554
Classification: IACT
XANTHAN GUMInactive
Code: TTV12P4NEE
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CEFACLOR - FDA Drug Approval Details